Patents by Inventor James Patrick O'Connor
James Patrick O'Connor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230113791Abstract: A mask interface for a respiratory mask, in which the mask interface comprises a resilient mask housing at least partially formed from a textile and being configured to deform under pressure from an external force, such as when being pressed against a pillow, and to substantially return to its original shape either automatically or by manipulation by a user.Type: ApplicationFiled: June 16, 2022Publication date: April 13, 2023Inventor: James Patrick O'Connor
-
Patent number: 11389612Abstract: A mask interface for a respiratory mask, in which the mask interface comprises a resilient mask housing at least partially formed from a textile and being configured to deform under pressure from an external force, such as when being pressed against a pillow, and to substantially return to its original shape either automatically or by manipulation by a user.Type: GrantFiled: September 26, 2017Date of Patent: July 19, 2022Assignee: Fisher & Paykel Healthcare LimitedInventor: James Patrick O'Connor
-
Publication number: 20220088271Abstract: The present invention is a method for producing allograft tissue by applying an antimicrobial solution to allograft tissue. The antimicrobial solution exhibits antimicrobial activity to make allograft resistant to microbial organisms, such as a bacterium.Type: ApplicationFiled: December 2, 2021Publication date: March 24, 2022Applicant: Rutgers, The State University of New JerseyInventors: Sheldon S. Lin, Joseph Benevenia, Michael J. Vives, Pradeep Kumar, David Alland, James Patrick O'Connor
-
Publication number: 20210330923Abstract: A respiratory mask system comprising a mask interface comprising a frame for a headgear assembly. The frame comprises a body comprising a first surface and a substantially opposing second surface. The body further comprises a gas inlet and optionally an outlet vent. The gas inlet may be substantially elliptical in shape. The frame may comprise a recessed region for receiving a yoke of a headgear assembly to attach the headgear to the mask interface. The respiratory mask system may also comprise a yoke for attaching to the frame.Type: ApplicationFiled: July 5, 2021Publication date: October 28, 2021Inventors: Melissa Catherine Bornholdt, Jonathan Mark Downey, Bruce Michael Walls, Adam Luke Gilbert, Janine Elizabeth Collins, Chris Onin Limpin Hipolito, Thomas Mark Richardson, Silas Sao Jin Siew, James Patrick O'Connor, Christopher John Large, Tony William Spear, Matthew Roger Stephenson, Paul Mathew Freestone, Jake Baker Hocking
-
Patent number: 11083862Abstract: A respiratory mask system comprising a mask interface comprising a frame for a headgear assembly. The frame comprises a body comprising a first surface and a substantially opposing second surface. The body further comprises a gas inlet and optionally an outlet vent. The gas inlet may be substantially elliptical in shape. The frame may comprise a recessed region for receiving a yoke of a headgear assembly to attach the headgear to the mask interface. The respiratory mask system may also comprise a yoke for attaching to the frame.Type: GrantFiled: March 15, 2017Date of Patent: August 10, 2021Assignee: Fisher & Paykel Healthcare LimitedInventors: Melissa Catherine Bornholdt, Jonathan Mark Downey, Bruce Michael Walls, Adam Luke Gilbert, Janine Elizabeth Collins, Chris Onin Limpin Hipolito, Thomas Mark Richardson, Silas Sao Jin Siew, James Patrick O'Connor, Christopher John Large, Tony William Spear, Matthew Roger Stephenson, Paul Mathew Freestone, Jake Baker Hocking
-
Publication number: 20190298958Abstract: A mask interface for a respiratory mask, in which the mask interface comprises a resilient mask housing at least partially formed from a textile and being configured to deform under pressure from an external force, such as when being pressed against a pillow, and to substantially return to its original shape either automatically or by manipulation by a user.Type: ApplicationFiled: September 26, 2017Publication date: October 3, 2019Inventor: James Patrick O'Connor
-
Publication number: 20190151592Abstract: A respiratory mask system comprising a mask interface comprising a frame for a headgear assembly. The frame comprises a body comprising a first surface and a substantially opposing second surface. The body further comprises a gas inlet and optionally an outlet vent. The gas inlet may be substantially elliptical in shape. The frame may comprise a recessed region for receiving yoke of a headgear assembly to attach the headgear to the mask interface. The respiratory mask system may also comprise a yoke for attaching to the frame.Type: ApplicationFiled: March 15, 2017Publication date: May 23, 2019Inventors: Melissa Catherine Bornholdt, Jonathan Mark Downey, Bruce Michael Walls, Adam Luke Gilbert, Janine Elizabeth Collins, Chris Onin Limpin Hipolito, Thomas Mark Richardson, Silas Sao Jin Siew, James Patrick O'Connor, Christopher John Large, Tony William Spear, Matthew Roger Stephenson, Paul Mathew Freestone, Jake Baker Hocking
-
Publication number: 20150320697Abstract: Methods for promoting osteogenesis to accelerate or enhance bone fracture healing, treat bone defects, and enhance bone formation are disclosed. The methods modulate an arachidonic acid metabolic or signaling pathway in general, and, in particular, utilize 5-lipoxygenase inhibitors. These molecules can be delivered alone or in combination with one or more agents that inhibit bone resorption, regulate calcium resorption from bone, enhance bone accumulation, enhance bone formation, induce bone formation, impair growth of microorganisms, reduce inflammation, and/or reduce pain.Type: ApplicationFiled: March 16, 2015Publication date: November 12, 2015Inventor: James Patrick O'Connor
-
Patent number: 9144633Abstract: The present invention discloses vanadium-based insulin-mimetic agent composite coatings, application of these coatings onto implantable devices, and use of the implantable devices for accelerating osseous healing. The invention also encompasses methods of manufacturing implantable devices coated with vanadium-based insulin-mimetic agent composite coatings and the implantable devices so manufactured. The implantable devices have wide applications, including but not limited to treating bone fracture, bone trauma, arthrodesis, and other bone deficit conditions, as well as bone injuries incurred in military and sports activities.Type: GrantFiled: December 9, 2011Date of Patent: September 29, 2015Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEYInventors: Sheldon S. Lin, David N. Paglia, James Patrick O'Connor, Eric Breitbart, Joseph Benevenia
-
Patent number: 8980851Abstract: Methods for promoting osteogenesis to accelerate or enhance bone fracture healing, treat bone defects, and enhance bone formation are disclosed. The methods modulate an arachidonic acid metabolic or signaling pathway in general, and, in particular, utilize 5-lipoxygenase inhibitors. These molecules can be delivered alone or in combination with one or more agents that inhibit bone resorption, regulate calcium resorption from bone, enhance bone accumulation, enhance bone formation, induce bone formation, impair growth of microorganisms, reduce inflammation, and/or reduce pain.Type: GrantFiled: November 5, 2010Date of Patent: March 17, 2015Assignee: Accelalox, Inc.Inventor: James Patrick O'Connor
-
Patent number: 8936804Abstract: This invention provides a method of promoting bone healing by locally administering a vanadium-based insulin mimetic agent to a patient in need thereof. The invention also provides a new use of insulin-mimetic vanadium compounds for manufacture of medicaments for accelerating bone-healing processes. In addition, the invention also encompasses a bone injury treatment kit suitable for localized administration of insulin-mimetic vanadium compounds or compositions thereof to a patient in need of such treatment.Type: GrantFiled: January 14, 2011Date of Patent: January 20, 2015Assignee: Rutgers, The State University of New JerseyInventors: Sheldon Suton Lin, David Naisby Paglia, James Patrick O'Connor, Eric Breitbart, Joseph Benevenia
-
Publication number: 20130171094Abstract: This invention provides a method of promoting bone healing by locally administering a vanadium-based insulin mimetic agent to a patient in need thereof. The invention also provides a new use of insulin-mimetic vanadium compounds for manufacture of medicaments for accelerating bone-healing processes. In addition, the invention also encompasses a bone injury treatment kit suitable for localized administration of insulin-mimetic vanadium compounds or compositions thereof to a patient in need of such treatment.Type: ApplicationFiled: January 14, 2011Publication date: July 4, 2013Applicant: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEYInventors: Sheldon Suton Lin, David Naisby Paglia, James Patrick O'Connor, Eric Breitbart, Joseph Benevenia
-
Publication number: 20110124717Abstract: Methods for promoting osteogenesis to accelerate or enhance bone fracture healing, treat bone defects, and enhance bone formation are disclosed. The methods modulate an arachidonic acid metabolic or signaling pathway in general, and, in particular, utilize 5-lipoxygenase inhibitors. These molecules can be delivered alone or in combination with one or more agents that inhibit bone resorption, regulate calcium resorption from bone, enhance bone accumulation, enhance bone formation, induce bone formation, impair growth of microorganisms, reduce inflammation, and/or reduce pain.Type: ApplicationFiled: November 5, 2010Publication date: May 26, 2011Applicant: ACCELALOX, INC.Inventor: James Patrick O'Connor
-
Publication number: 20110105959Abstract: Methods for promoting osteogenesis to accelerate or enhance bone fracture healing, treat bone defects, and enhance bone formation are disclosed. The methods rely on in vivo or ex vivo modulation of an arachidonic acid metabolic or signaling pathway in general, and, in particular, utilize 5-lipoxygenase inhibitors, leukotriene A4 hydrolase inhibitors, and/or leukotriene B4 receptor antagonists. These molecules can be delivered alone or in combination with one or more agents that inhibit bone resorption, regulate calcium resorption from bone, enhance bone accumulation, enhance bone formation, induce bone formation, impair growth of microorganisms, reduce inflammation, and/or reduce pain.Type: ApplicationFiled: August 20, 2010Publication date: May 5, 2011Applicant: ACCELALOX, INC.Inventor: James Patrick O'Connor
-
Patent number: 7829535Abstract: Methods for promoting osteogenesis to accelerate or enhance bone fracture healing, treat bone defects, and enhance bone formation are disclosed. The methods modulate an arachidonic acid metabolic or signaling pathway in general, and, in particular, utilize 5-lipoxygenase inhibitors. These molecules can be delivered alone or in combination with one or more agents that inhibit bone resorption, regulate calcium resorption from bone, enhance bone accumulation, enhance bone formation, induce bone formation, impair growth of microorganisms, reduce inflammation, and/or reduce pain.Type: GrantFiled: August 18, 2006Date of Patent: November 9, 2010Assignee: Accelalox, Inc.Inventor: James Patrick O'Connor
-
Patent number: 7763582Abstract: A method of promoting bone healing in a non-diabetic patient in need thereof by locally administering a therapeutically effective amount of insulin to the patient. A drug delivery device, which includes insulin and a pharmaceutically acceptable carrier, wherein the device is adapted for localized administration of insulin to a patient in need thereof is also presented.Type: GrantFiled: February 21, 2007Date of Patent: July 27, 2010Assignee: University of Medicine and Dentistry Of New JerseyInventors: Sheldon Suton Lin, Ankur Gandhi, James Patrick O'Connor, Loay A. Al-Zube, Joseph Benevenia, J. Russell Parsons
-
Publication number: 20090214468Abstract: A method of promoting bone healing in a non-diabetic patient in need thereof by locally administering a therapeutically effective amount of insulin to the patient. A drug delivery device, which includes insulin and a pharmaceutically acceptable carrier, wherein the device is adapted for localized administration of insulin to a patient in need thereof is also presented.Type: ApplicationFiled: February 21, 2007Publication date: August 27, 2009Applicant: The University Of Medicine and Dentistry Of New JerseyInventors: Sheldon Suton Lin, Ankur Gandhi, James Patrick O'Connor, Loay A. Al-Zube, Joseph Benevenia, J. Russell Parsons
-
Publication number: 20080280826Abstract: Methods for promoting osteogenesis to accelerate or enhance bone fracture healing, treat bone defects, and enhance bone formation are disclosed. The methods modulate an arachidonic acid metabolic or signaling pathway in general, and, in particular, utilize 5-lipoxygenase inhibitors. These molecules can be delivered alone or in combination with one or more agents that inhibit bone resorption, regulate calcium resorption from bone, enhance bone accumulation, enhance bone formation, induce bone formation, impair growth of microorganisms, reduce inflammation, and/or reduce pain.Type: ApplicationFiled: August 18, 2006Publication date: November 13, 2008Applicant: ACCELALOX, INC.Inventor: James Patrick O'Connor
-
Patent number: D642166Type: GrantFiled: April 28, 2010Date of Patent: July 26, 2011Assignee: Open Range Communications Inc.Inventors: William S. Beans, Jr., Shihchieh Chou, John C. Hockemeier, James Patrick O'Connor, Keith D. Paglusch